Navigation Links
Colorado2 Spinal System

ProductsColorado2 Spinal System
Company Medtronic Neurological and Spinal
Item Colorado2 Spinal System
Features Colorado2 Spinal system comes with innovative and ergonomically designed instruments that further improving the process of placement of spinal instrumentation. Rods are made of a special stainless steel alloy that provides high mechanical strength and fatigue resistance while maintaining flexibility. There is 34 degrees of variability when the rod and clamp are connected to the spinal implant. Combination of rod flexibility and rod-clamp variability allows the surgeon to attach the spine to the rod at multiple points before applying the corrective force to the deformity.
Description Colorado2 Spinal system was designed to allow for three-dimensional correction of a variety of spinal deformities using flexible rods with excellent fatigue resistance to provide solid stabilization for spinal fusion. Colorado2 system combines a new dimension in flexibility in reducing the spinal column to a fusion rod with unparalleled durability and ease of use when applying, connecting, and tightening the hardware used for fixation.
Info Medtronic Neurological and Spinal
Customer Service: (800) 510-6735
Web site: http://www.medtronic.com/neuro/

Related medicine products :

1. Ruggles Spinal Retraction System
2. Summit SI Spinal Fixation System
3. TEW Cranial/Spinal Retractor (A 1090)
4. Panther Universal Spinal Retractor System
5. Bookwalter Spinal Retractor
6. Karlin Crank Frame Spinal Retractor Set
7. Cervical Spinal Compression Plate Acc. To Matzen
8. Semmes Spinal Fusion Curette
9. Cobb Spinal Curette
10. Spinal Fusion Curette
11. Equation Spinal System
FCY-15P2 - Slim Cystoscope
Shoelly Cystoscopes
Continuous Flow Cystoscopes
The Prostatron® System
Medicine Products:
(Date:12/2/2009)...ce of obesity could counter recent increases in lo... News) -- The overall health of the U.S. populatio...y because people have quit smoking in droves, but ...ed out if the rising obesity rates among Americans...n both smoking and obesity continue unchanged, the...
(Date:12/2/2009)... life remains unclear, researchers say , ...rch suggests that enzyme replacement therapy can m... Fabry disease, a rare illness that affects the ki...ase, linked to the lack of an enzyme that helps me...l because it boosts the risk for a stroke, heart a...
(Date:12/2/2009)...H, Va., Dec. 2 By now, most people...garettes continue to grow in popularity. And, the ...he PremiumEcigarette - the new single piece Premiu...amazingly low price of $14.99. ,, "This new pro...arette at a very low price, before making a bigger...
(Date:12/2/2009)... New Directors Represent Diverse Healthcare Stakeh...ewswire/ -- The membership of the National Quality... of Directors and reappointed four current Board m...ge of healthcare stakeholders, including consumers...and community healthcare. ,, The newly elected...
(Date:12/2/2009)... Dec. 2 Independence Blue Cross (I...ct with Lincoln Financial Group. IBC will be the p...ely 10,000 Lincoln Financial Group employees, reti...Lincoln plan offerings will include the PPO option...now I speak for all of us at Independence Blue Cro...
Breaking Medicine News(10 mins):Health News:Health Gains From Lowered Smoking Rates in Jeopardy 2Health News:Health Gains From Lowered Smoking Rates in Jeopardy 3Health News:A Smokeless Holiday Season? Premium Electronic Cigarette Announces New Disposable Smokeless Cigarette Product 2Health News:National Quality Forum Members Elect Nine Directors to Board 2Health News:National Quality Forum Members Elect Nine Directors to Board 3Health News:Independence Blue Cross Secures All-Blue Contract with Lincoln Financial Group 2Health News:Independence Blue Cross Secures All-Blue Contract with Lincoln Financial Group 3
...n international research consortium investigating ...itions has identified a new genetic risk factor fo...hose suffering from coeliac disease lack a protect...and the Hap Map Project, international research ef...
...f reports are to be believed, then the "medical co...from jail early, only to be thrown back inside a ...smitted infection. According to the News of t...ion Center decided to remove her from jail and pla...
...hear-thickening fluids - which increase in stiffne...seful for making better body armour, researchers ... have said. The idea is to fill an armoured...rment would be soft and flexible, giving the weare...
...omen might soon not have to worry about the tickin...on the verge of developing drugs that could delay ...ty expert Professor Robert Winston who told a pres... The news sends new hope to women who want to put...
...atest research suggests that drinking a glass of c...der, a beverage made from the fermented juices of ...inks and has a 2,000-year-old tradition. It origin... France, Ireland and northern Spain. World over, c...
...he study, published in the June issue of CHEST, re...irst year of life were at greater risk for develop...biotics. The risk for asthma doubled in chil...dog during the first year. Antibiotics ar...
Other Medicine News:Health News:Genetic Risk Factor for Coeliac Disease Identified. 2Health News:Paris' 'medical Condition' is a Sexually Transmitted Infection 2Health News:Scientists Have Found Way to Delay Menopause 2Health News:Antibiotic Use in Infants may Lead to Asthma. 2
(Date:12/2/2009)... , NEW YORK, Dec. 2 Reportlink... is available in its catalogue: ,, EEG/EMG/Br..., http://www.reportlinker.com/p0164319/EEG/EMG...html ,, Steep rise in obesity, cardiovascular,...ctroencephalograph (EEG) diagnostic and monitoring...
(Date:12/2/2009)...ST. LOUIS, Dec. 2 KV Pha...t that it has entered into an employment agreement...r David A. Van Vliet with a term through December ...ident and Chief Executive Officer since December 2...nuity of senior leadership as the Company seeks to...
(Date:12/2/2009)... , NEW YORK, Dec. 2 Reportlink... is available in its catalogue: ,, Hepatitis C...t Trends & Opportunities ,, http://www.re...apeutics---A-Global-Update-of-Market-Trends--Oppor...or all these years of meager clinical outcomes owi...
Breaking Medicine Technology:Reportlinker Adds EEG/EMG/Brain Function Monitoring - Global Market Trends 2Reportlinker Adds EEG/EMG/Brain Function Monitoring - Global Market Trends 3Reportlinker Adds EEG/EMG/Brain Function Monitoring - Global Market Trends 4Reportlinker Adds EEG/EMG/Brain Function Monitoring - Global Market Trends 5Reportlinker Adds EEG/EMG/Brain Function Monitoring - Global Market Trends 6Reportlinker Adds EEG/EMG/Brain Function Monitoring - Global Market Trends 7Reportlinker Adds EEG/EMG/Brain Function Monitoring - Global Market Trends 8KV Pharmaceutical Enters Into Employment Agreement with Interim President and Chief Executive Officer David A. Van Vliet 2Reportlinker Adds Hepatitis C Virus and Therapeutics - A Global Update of Market Trends & Opportunities 2Reportlinker Adds Hepatitis C Virus and Therapeutics - A Global Update of Market Trends & Opportunities 3Reportlinker Adds Hepatitis C Virus and Therapeutics - A Global Update of Market Trends & Opportunities 4Reportlinker Adds Hepatitis C Virus and Therapeutics - A Global Update of Market Trends & Opportunities 5Reportlinker Adds Hepatitis C Virus and Therapeutics - A Global Update of Market Trends & Opportunities 6Reportlinker Adds Hepatitis C Virus and Therapeutics - A Global Update of Market Trends & Opportunities 7Reportlinker Adds Hepatitis C Virus and Therapeutics - A Global Update of Market Trends & Opportunities 8Caliper Life Sciences Third Quarter 2009 Financial Results Conference Call Notice 59856 1Caliper Life Sciences Third Quarter 2009 Financial Results Conference Call Notice 59856 2Epeius Biotechnologies to Partner at BIO Investor Forum 14548 1Epeius Biotechnologies to Partner at BIO Investor Forum 14548 2Pulmo BioTech Inc Announces Letter of Intent Regarding Proposed License of its Pulmonary Vascular Diagnostic Product Candidate PulmoBind 28TM 29 5618 1Pulmo BioTech Inc Announces Letter of Intent Regarding Proposed License of its Pulmonary Vascular Diagnostic Product Candidate PulmoBind 28TM 29 5618 2Pulmo BioTech Inc Announces Letter of Intent Regarding Proposed License of its Pulmonary Vascular Diagnostic Product Candidate PulmoBind 28TM 29 5618 3Pulmo BioTech Inc Announces Letter of Intent Regarding Proposed License of its Pulmonary Vascular Diagnostic Product Candidate PulmoBind 28TM 29 5618 4